DRUG
Income statement / Annual
Last year (2023), Bright Minds Biosciences Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Bright Minds Biosciences Inc.'s net income was -$7.37 M.
See Bright Minds Biosciences Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$72,450.00 |
$6,037.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$72,450.00 |
-$6,037.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$5.00 M
|
$12.18 M
|
$6.31 M
|
$354,852.00
|
$42,009.00
|
| General & Administrative
Expenses |
$2.08 M
|
$2.00 M
|
$1.44 M
|
$104,888.00
|
$110,124.00
|
| Selling & Marketing
Expenses |
$119,418.00
|
$551,864.00
|
$852,151.00
|
$9,618.00
|
$36,597.00
|
| Selling, General &
Administrative Expenses |
$2.20 M
|
$2.55 M
|
$2.29 M
|
$114,506.00
|
$36,708.00
|
| Other Expenses |
$0.00 |
-$243,079.00 |
-$181,743.00 |
-$5,451.00 |
$0.00 |
| Operating Expenses |
$7.21 M |
$14.73 M |
$8.60 M |
$469,358.00 |
$78,717.00 |
| Cost And Expenses |
$7.21 M |
$14.73 M |
$8.60 M |
$469,358.00 |
$78,717.00 |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$19,750.00 |
$222,777.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$72,450.00
|
$6,037.00
|
$8.62 M
|
$474,926.00
|
$236,151.00
|
| EBITDA |
-$7.33 M
|
-$14.74 M
|
-$8.76 M
|
-$469,358.00
|
-$78,720.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$157,292.00
|
-$222,777.00
|
$107,790.00
|
-$11,019.00
|
$3.00
|
| Income Before Tax |
-$7.37 M |
-$14.96 M |
-$8.65 M |
-$480,377.00 |
-$78,717.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$14,189.00 |
$222,777.00 |
-$135,434.00 |
$5,568.00 |
-$236.15 |
| Net Income |
-$7.37 M |
-$15.19 M |
-$8.52 M |
-$485,945.00 |
-$78,717.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.98 |
-6.15 |
-4.74 |
-0.38 |
-0.0615 |
| EPS Diluted |
-1.98 |
-6.15 |
-4.74 |
-0.38 |
-0.0615 |
| Weighted Average Shares
Out |
$3.72 M
|
$2.47 M
|
$1.79 M
|
$1.28 M
|
$1.28 M
|
| Weighted Average Shares
Out Diluted |
$3.72 M
|
$2.47 M
|
$1.79 M
|
$1.28 M
|
$1.28 M
|
| Link |
|
|
|
|
|
